• Profile
Close

Administration of erythropoiesis-stimulating agents in patients undergoing haemodialysis: A time and motion study

Journal of Renal Care Sep 23, 2017

Johnson DW, et al. - The objective of this study is to document the time required and the cost in terms of nursing time to prepare and administer erythropoiesis-stimulating agents (ESAs) to patients on facility-based haemodialysis (HD) with anaemia because of chronic kidney disease (CKD) before and after the introduction of long-acting ESAs. Switching from a short-acting to a long-acting ESA in HD units leads to an important reduction in time costs of health professionals in preparation and administration of ESAs by up to 80%.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay